AmerisourceBergen (ABC), one of the nation’s largest pharmaceutical wholesalers, is eliminating 225 jobs — roughly 15 percent of the entire workforce — at Pharmedium Services, its troubled compounding unit that has concerned regulators and rattled investors.
The cuts are being made specifically at a beleaguered Memphis plant, where operations were suspended nearly a year ago and product recalls were issued due to sterile manufacturing issues, all of which followed an inspection by the Food and Drug Administration.
And in late 2017, AmerisourceBergen also received a grand jury subpoena from the U.S. Attorney in Memphis seeking various documents, including information related to the laboratory testing procedures and products packaged in a certain type of syringe.
About the Author Reprints
The reason why I only use one extremely careful, and well know to the communities of compounding pharmacies, for their ethics and integrity of themselves and the products that they use for the compound process. A clean and compassionate place for anyone who has to have a compound prescription. The one that I use, is the only one that I ever would want for my own medications. I consider myself to be a very fortunate individual to have this pharmacy for myself.
Perhaps they need to re-brand this unit – “Pharminimum.” (Another source of ‘adulterated drugs’ that FDA cannot stop ‘at the waters edge.’)